Business Practice

In this video interview, Mike Rea explains why each drug needs its own launch strategy.

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

We speak with the authors of two studies into extreme increases in US drug pricing, and attempts by lawmakers to bring the price-jackers into line.

We get the lowdown on the Reputation Index, which was recently published by the Association of the British Pharmaceutical Industry.

The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?

Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Sweden.

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Mike Rea of IDEA Pharma shares his thoughts on what players in pharma positioning are getting right – and wrong.

How a drug approval changed the lives of patients living with rare disease.

Defining the best strategies for working with highly potent drug substances.